> ## Content Index
> Fetch the complete content index at: https://www.coios.me/llms.txt
> Use this file to discover other available public pages before exploring further.

# Transvalvular pump in infarct-related cardiogenic shock costs €36,083 per QALY in Germany
- URL: https://www.coios.me/transvalvular-pump-in-infarct-related-cardiogenic-shock/
- Published: 2026-11-19T13:08:57.000Z
- Updated: 2026-11-19T16:01:02.000Z
- Description: A lifetime model puts a microaxial flow pump in infarct-related cardiogenic shock at €36,083 per QALY for German statutory insurers.
- Author: Daniel Ryan
- Tags: Data, models and systems, Value in health, Heart and stroke, Germany, #peer-reviewed, #new, #item, #source-2026-11, #score-68

This study modelled the cost-effectiveness of a transvalvular microaxial flow pump in infarct-related cardiogenic shock, for German statutory insurers. A cohort state-transition model used trial outcomes for 180 days, then chronic states with or without heart failure. The pump gave 1.06 extra QALYs at €38,121 more, or €36,083 per QALY, discounted at 3%. At an illustrative threshold of €50,000 per QALY, the probability of cost-effectiveness was 86%. Bleeding (21.8% vs 11.9%) and limb ischaemia (5.6% vs 1.1%) were more frequent with the pump. Acute payments were assumed equal between arms, and net monetary benefit remained positive below an acute payment difference of €14,703.

*Why it is interesting: The pump lowered 180-day mortality but raised bleeding and limb ischaemia, and the model weighs both. The result depends on acute hospital payments not yet measured by arm.*

Source

[Expert Review of Pharmacoeconomics & Outcomes Research, 18 November 2026](https://doi.org/10.1080/14737167.2026.2767331?ref=coios.me)

DOI

10.1080/14737167.2026.2767331

Type

Peer-reviewed article

Design

Cohort state-transition cost-utility model, German statutory health insurance perspective, lifetime horizon with 180-day acute phase from trial outcomes (NCT01633502), 2023 euros, 3% discounting, probabilistic and threshold sensitivity analysis

Verdict

New finding

Driver

[Value in health](https://www.coios.me/d-health-economics/)

Driver

[Heart and stroke](https://www.coios.me/d-cardiovascular/)